β-Defensins activate human mast cells via mas-related gene X2

Journal of Immunology

Volumn 191, Issue 1, 2013, Pages 345-352

  Subramanian, Hariharan ^a   Gupta, Kshitij ^a   Lee, Donguk ^a   Bayir, Arzu K ^a   Ahn, Harry ^a   Ali, Hydar ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; ANAPHYLATOXIN; BETA DEFENSIN; BETA DEFENSIN 2; BETA DEFENSIN 3; CALCIUM ION; COMPLEMENT COMPONENT C3A; G PROTEIN COUPLED RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; LANTHANUM; PERTUSSIS TOXIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; BONE MARROW; CALCIUM TRANSPORT; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MAST CELL; MAST CELL DEGRANULATION; MAST CELL LEUKEMIA; MOUSE; MRGX2 GENE; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BETA-DEFENSINS; CALCIUM SIGNALING; CELL DEGRANULATION; CELL LINE; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; HUMANS; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE;

EID: 84879623977     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300023     Document Type: Article

References (50)

1. Weinberg, A., G. Jin, S. Sieg, and T. S. McCormick. 2012. The yin and yang of human beta-defensins in health and disease. Front. Immunol. 3: 294.
2. Tohidnezhad, M., D. Varoga, R. Podschun, C. J. Wruck, A. Seekamp, L. O. Brandenburg, T. Pufe, and S. Lippross. 2011. Thrombocytes are effectors of the innate immune system releasing human beta defensin-3. Injury 42: 682-686.
3. Funderburg, N., M. M. Lederman, Z. Feng, M. G. Drage, J. Jadlowsky, C. V. Harding, A. Weinberg, and S. F. Sieg. 2007. Human-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc. Natl. Acad. Sci. USA 104: 18631-18635. (Pubitemid 350210748)
4. Biragyn, A., P. A. Ruffini, C. A. Leifer, E. Klyushnenkova, A. Shakhov, O. Chertov, A. K. Shirakawa, J. M. Farber, D. M. Segal, J. J. Oppenheim, and L. W. Kwak. 2002. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298: 1025-1029. (Pubitemid 35247310)
5. Röhrl, J., D. Yang, J. J. Oppenheim, and T. Hehlgans. 2010. Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J. Immunol. 184: 6688-6694.
6. Jin, G., H. I. Kawsar, S. A. Hirsch, C. Zeng, X. Jia, Z. Feng, S. K. Ghosh, Q. Y. Zheng, A. Zhou, T. M. McIntyre, and A. Weinberg. 2010. An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. PLoS One 5: e10993.
7. Conejo-Garcia, J. R., F. Benencia, M. C. Courreges, E. Kang, A. Mohamed-Hadley, R. J. Buckanovich, D. O. Holtz, A. Jenkins, H. Na, L. Zhang, et al. 2004. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat. Med. 10: 950-958. (Pubitemid 39273736)
8. Irani, A. A., N. M. Schechter, S. S. Craig, G. DeBlois, and L. B. Schwartz. 1986. Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci. USA 83: 4464-4468. (Pubitemid 16057069)
9. Galli, S. J., N. Borregaard, and T. A. Wynn. 2011. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol. 12: 1035-1044.
10. Niyonsaba, F., A. Someya, M. Hirata, H. Ogawa, and I. Nagaoka. 2001. Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur. J. Immunol. 31: 1066-1075.
11. Chen, X., F. Niyonsaba, H. Ushio, M. Hara, H. Yokoi, K. Matsumoto, H. Saito, I. Nagaoka, S. Ikeda, K. Okumura, and H. Ogawa. 2007. Antimicrobial peptides human beta-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability. Eur. J. Immunol. 37: 434-444. (Pubitemid 46915583)
12. Subramanian, H., K. Gupta, Q. Guo, R. Price, and H. Ali. 2011. Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization. J. Biol. Chem. 286: 44739-44749.
13. Burstein, E. S., T. R. Ott, M. Feddock, J. N. Ma, S. Fuhs, S. Wong, H. H. Schiffer, M. R. Brann, and N. R. Nash. 2006. Characterization of the Mas-related gene family: structural and functional conservation of human and rhesus MrgX receptors. Br. J. Pharmacol. 147: 73-82. (Pubitemid 43069098)
14. Schäfer, B., A. M. Piliponsky, T. Oka, C. H. Song, N. P. Gerard, C. Gerard, M. Tsai, J. Kalesnikoff, and S. J. Galli. 2013. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. J. Allergy Clin. Immunol. 131: 541-548, e1-e9.
15. Radinger, M., B. M. Jensen, H. S. Kuehn, A. Kirshenbaum, and A. M. Gilfillan. 2010. Generation, isolation, and maintenance of human mast cells and mast cell lines derived from peripheral blood or cord blood. Curr. Protoc. Immunol.Chapter 7: Unit 7.37.
16. Kirshenbaum, A. S., C. Akin, Y. Wu, M. Rottem, J. P. Goff, M. A. Beaven, V. K. Rao, and D. D. Metcalfe. 2003. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk. Res. 27: 677-682. (Pubitemid 36683255)
17. Ali, H., R. M. Richardson, E. D. Tomhave, R. A. DuBose, B. Haribabu, and R. Snyderman. 1994. Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells: role of multiple G proteins and receptor phosphorylation. J. Biol. Chem. 269: 24557-24563.
18. Subramanian, H., S. W. Kashem, S. J. Collington, H. Qu, J. D. Lambris, and H. Ali. 2011. PMX-53 as a dual CD88 antagonist and an agonist for Mas-related gene 2 (MrgX2) in human mast cells. Mol. Pharmacol. 79: 1005-1013.
19. Kashem, S. W., H. Subramanian, S. J. Collington, P. Magotti, J. D. Lambris, and H. Ali. 2011. G protein coupled receptor specificity for C3a and compound 48/ 80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2. Eur. J. Pharmacol. 668: 299-304.
20. Vibhuti, A., K. Gupta, H. Subramanian, Q. Guo, and H. Ali. 2011. Distinct and shared roles of β-arrestin-1 and β-arrestin-2 on the regulation of C3a receptor signaling in human mast cells. PLoS One 6: e19585.
21. Hazlett, L., and M. Wu. 2011. Defensins in innate immunity. Cell Tissue Res. 343: 175-188.
22. Jung, S., J. Mysliwy, B. Spudy, I. Lorenzen, K. Reiss, C. Gelhaus, R. Podschun, M. Leippe, and J. Grötzinger. 2011. Human beta-defensin 2 and beta-defensin 3 chimeric peptides reveal the structural basis of the pathogen specificity of their parent molecules. Antimicrob. Agents Chemother. 55: 954-960.
23. Niyonsaba, F., H. Ushio, M. Hara, H. Yokoi, M. Tominaga, K. Takamori, N. Kajiwara, H. Saito, I. Nagaoka, H. Ogawa, and K. Okumura. 2010. Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells. J. Immunol. 184: 3526-3534.
24. Chang, W. C., J. Di Capite, K. Singaravelu, C. Nelson, V. Halse, and A. B. Parekh. 2008. Local Ca2+ influx through Ca2+ release-activated Ca2+ (CRAC) channels stimulates production of an intracellular messenger and an intercellular pro-inflammatory signal. J. Biol. Chem. 283: 4622-4631.
25. Hide, M., and M. A. Beaven. 1991. Calcium influx in a rat mast cell (RBL-2H3) line: use of multivalent metal ions to define its characteristics and role in exocytosis. J. Biol. Chem. 266: 15221-15229. (Pubitemid 21907638)
26. Schindl, R., H. Kahr, I. Graz, K. Groschner, and C. Romanin. 2002. Store depletion-activated CaT1 currents in rat basophilic leukemia mast cells are inhibited by 2-aminoethoxydiphenyl borate: evidence for a regulatory component that controls activation of both CaT1 and CRAC (Ca(2+) release-activated Ca(2+) channel) channels. J. Biol. Chem. 277: 26950-26958. (Pubitemid 34951705)
27. Sick, E., S. Brehin, P. André, G. Coupin, Y. Landry, K. Takeda, and J. P. Gies. 2010. Advanced glycation end products (AGEs) activate mast cells. Br. J. Pharmacol. 161: 442-455.
28. Lee, H. S., C. S. Park, Y. M. Lee, H. Y. Suk, T. C. Clemons, and O. H. Choi. 2005. Antigen-induced Ca2+ mobilization in RBL-2H3 cells: role of I(1,4,5)P3 and S1P and necessity of I(1,4,5)P3 production. Cell Calcium 38: 581-592.
29. Yang, D., O. Chertov, S. N. Bykovskaia, Q. Chen, M. J. Buffo, J. Shogan, M. Anderson, J. M. Schröder, J. M. Wang, O. M. Howard, and J. J. Oppenheim. 1999. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286: 525-528.
30. Niyonsaba, F., K. Iwabuchi, H. Matsuda, H. Ogawa, and I. Nagaoka. 2002. Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Int. Immunol. 14: 421-426. (Pubitemid 34257769)
31. Soruri, A., J. Grigat, U. Forssmann, J. Riggert, and J. Zwirner. 2007. beta- Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. Eur. J. Immunol. 37: 2474-2486. (Pubitemid 47423617)
32. Tatemoto, K., Y. Nozaki, R. Tsuda, S. Konno, K. Tomura, M. Furuno, H. Ogasawara, K. Edamura, H. Takagi, H. Iwamura, et al. 2006. Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors. Biochem. Biophys. Res. Commun. 349: 1322-1328. (Pubitemid 44416402)
33. Chen, X., F. Niyonsaba, H. Ushio, I. Nagaoka, S. Ikeda, K. Okumura, and H. Ogawa. 2006. Human cathelicidin LL-37 increases vascular permeability in the skin via mast cell activation, and phosphorylates MAP kinases p38 and ERK in mast cells. J. Dermatol. Sci. 43: 63-66. (Pubitemid 43817496)
34. Koczulla, R., G. von Degenfeld, C. Kupatt, F. Krötz, S. Zahler, T. Gloe, K. Issbrücker, P. Unterberger,M. Zaiou, C. Lebherz, et al. 2003. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111: 1665-1672. (Pubitemid 38057748)
35. Nizet, V., T. Ohtake, X. Lauth, J. Trowbridge, J. Rudisill, R. A. Dorschner, V. Pestonjamasp, J. Piraino, K. Huttner, and R. L. Gallo. 2001. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454-457. (Pubitemid 34173727)
36. Di Nardo, A., A. Vitiello, and R. L. Gallo. 2003. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 170: 2274-2278. (Pubitemid 36245611)
37. Semple, F., S. Webb, H. N. Li, H. B. Patel, M. Perretti, I. J. Jackson, M. Gray, D. J. Davidson, and J. R. Dorin. 2010. Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo. Eur. J. Immunol. 40: 1073-1078.
38. Röhrl, J., B. Huber, G. E. Koehl, E. K. Geissler, and T. Hehlgans. 2012. Mouse β-defensin 14 (Defb14) promotes tumor growth by inducing angiogenesis in a CCR6-dependent manner. J. Immunol. 188: 4931-4939.
39. Irani, A. M., and L. B. Schwartz. 1989. Mast cell heterogeneity. Clin. Exp. Allergy 19: 143-155.
40. Scudamore, C. L., L. McMillan, E. M. Thornton, S. H. Wright, G. F. Newlands, and H. R. Miller. 1997. Mast cell heterogeneity in the gastrointestinal tract: variable expression of mouse mast cell protease-1 (mMCP-1) in intraepithelial mucosalmast cells in nematode-infected and normal BALB/c mice. Am. J. Pathol. 150: 1661-1672. (Pubitemid 27193814)
41. Tainsh, K. R., W. L. Liu, H. Y. Lau, J. Cohen, and F. L. Pearce. 1992. Mast cell heterogeneity in man: unique functional properties of skin mast cells in response to a range of polycationic stimuli. Immunopharmacology 24: 171-180. (Pubitemid 23003854)
42. Dong, X., S. Han, M. J. Zylka, M. I. Simon, and D. J. Anderson. 2001. A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell 106: 619-632. (Pubitemid 32879323)
43. Kajiwara, N., T. Sasaki, P. Bradding, G. Cruse, H. Sagara, K. Ohmori, H. Saito, C. Ra, and Y. Okayama. 2010. Activation of human mast cells through the platelet-activating factor receptor. J. Allergy Clin. Immunol. 125: 1137-1145.e6.
44. Robas, N., E. Mead, and M. Fidock. 2003. MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion. J. Biol. Chem. 278: 44400-44404. (Pubitemid 37377189)
45. Zylka, M. J., X. Dong, A. L. Southwell, and D. J. Anderson. 2003. Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family. Proc. Natl. Acad. Sci. USA 100: 10043-10048. (Pubitemid 37087065)
46. Schiemann, F., E. Brandt, R. Gross, B. Lindner, J. Mittelstädt, C. P. Sommerhoff, J. Schulmistrat, and F. Petersen. 2009. The cathelicidin LL-37 activates human mast cells and is degraded by mast cell tryptase: counter-regulation by CXCL4. J. Immunol. 183: 2223-2231.
47. Kurosaka, K., Q. Chen, F. Yarovinsky, J. J. Oppenheim, and D. Yang. 2005. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J. Immunol. 174: 6257-6265. (Pubitemid 40663818)
48. McNeil, H. P., K. Shin, I. K. Campbell, I. P. Wicks, R. Adachi, D. M. Lee, and R. L. Stevens. 2008. The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis. Arthritis Rheum. 58: 2338-2346.
49. Venkatesha, R. T., E. Berla Thangam, A. K. Zaidi, and H. Ali. 2005. Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase. Mol. Immunol. 42: 581-587. (Pubitemid 39655936)
50. Ishikawa, T., N. Kanda, C. S. Hau, Y. Tada, and S. Watanabe. 2009. Histamine induces human beta-defensin-3 production in human keratinocytes. J. Dermatol. Sci. 56: 121-127.